
    
      Protocol No: TLC599A1001

      Name of Finished Product: TLC599

      Title of Study:

      A Randomized, Open-label, Parallel, Phase I/II Single-Dose Administration trial of TLC599 in
      Subjects with Osteoarthritis (OA) of the Knee

      Methodology This trial is a multi-site, randomized, open-label, parallel, and single-dose
      administration study to investigate the safety and efficacy of TLC599 in subjects with
      osteoarthritis of the knee.

      Study duration:

      The trial will last 14 weeks including a 14-day screening period and a 12-week follow-up
      period.
    
  